{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"54.9","upperLimit":"90.6","value":"76"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"The Rate Of Gross-Total or Near-Total Resection With Second Surgery After Chemotherapy Treatment.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive initial course of chemotherapy comprising vincristine sulfate IV on days 1 and 8, carboplatin IV over 1 hour on day 1, and cyclophosphamide IV over 1 hour on days 1 and 2. Patients also receive filgrastim (G-CSF) subcutaneously or IV beginning on day 3 and continuing until blood counts recover. Patients then receive a second course of chemotherapy comprising vincristine sulfate IV on days 1 and 8, carboplatin IV over 1 hour on day 1, and oral etoposide on days 1-21. After completion of chemotherapy, patients are evaluated for second therapeutic conventional surgery. Patients who have unresectable disease undergo conformal radiation therapy. Patients who have resectable disease undergo second surgery followed by conformal radiotherapy.\n\nfilgrastim: Given IV or SC (5mcg/kg/day) start on Day 3 and continue until ANC \\>1500/μl given subcutaneously or intravenously.\n\ncarboplatin: Given IV (375 mg/m2/day) Day 1 given as an IV infusion over one hour. For patient","id":"OG000","title":"Sub-Total Resection Any Histology or Location (STR) (Group 3)"}],"paramType":"NUMBER","populationDescription":"Of 64 eligible patients in this group, 25 patients after chemotherapy had the second surgery. Of 25 patients with second surgery after chemotherapy, 19 had a Gross-Total or Near-Total resection. 19/25=76%.","reportingStatus":"POSTED","timeFrame":"At the time of second surgery","title":"Rate of Gross-total or Near-total Resection and Second Surgery After Chemotherapy","type":"SECONDARY","unitOfMeasure":"percentage of participants"}